Search

Your search keyword '"Kaderali, Lars"' showing total 699 results

Search Constraints

Start Over You searched for: Author "Kaderali, Lars" Remove constraint Author: "Kaderali, Lars"
699 results on '"Kaderali, Lars"'

Search Results

301. Mechanistic modeling explains the dsRNA length-dependent activation of the RIG-I mediated immune response.

302. Classification of Glioblastoma Multiforme Patients Based on an Integrative Multi-Layer Finite Mixture Model System

303. Efficient inactivation of pseudotyped HIV-based lentiviral vectors and infectious HIV.

304. Computational modeling of miRNA-mediated gene regulation in consideration of miRNP binding information from AGO-bound CLIP-Seq data analysis

305. Natural history of anal dysplasia in an HIV-infected clinical care cohort: estimates using multi-state Markov modeling

306. Data Mining Strategies to Improve Multiplex Microbead Immunoassay Tolerance in a Mouse Model of Infectious Diseases

307. Phosphorylation-Dependent Feedback Inhibition of RIG-I by DAPK1 Identified by Kinome-wide siRNA Screening.

308. Real world federated learning with a knowledge distilled transformer for cardiac CT imaging.

309. Seroprevalence and silent infection rate during SARS-CoV-2 pandemic among children and adolescents in Western Pomerania: a multicenter, cross-sectional study-the COVIDKID study.

310. Immunofluorescence microscopy on the blood smear identifies patients with myeloproliferative neoplasms.

311. Identification of dihydromyricetin as a natural DNA methylation inhibitor with rejuvenating activity in human skin.

312. Landscape of protein-protein interactions during hepatitis C virus assembly and release.

313. Development of an epigenetic clock to predict visual age progression of human skin.

314. Neighbourhood watch: genomic epidemiology of SARS-CoV-2 variants circulating in a German federal state, Mecklenburg-Western Pomerania, in 2020-2022.

315. High-resolution kinetic characterization of the RIG-I-signaling pathway and the antiviral response.

316. Vaccine-hesitant individuals accumulate additional COVID-19 risk due to divergent perception and behaviors related to SARS-CoV-2 testing: a population-based, cross-sectional study.

317. Evaluating heart rate variability with 10 second multichannel electrocardiograms in a large population-based sample.

318. Virus variant-specific clinical performance of SARS coronavirus two rapid antigen tests in point-of-care use, from November 2020 to January 2022.

319. Virotherapy combined with anti-PD-1 transiently reshapes the tumor immune environment and induces anti-tumor immunity in a preclinical PDAC model.

320. Cohort Profile Update: The Study of Health in Pomerania (SHIP).

321. Quantitative interpretation of PF4/heparin-EIA optical densities in predicting platelet-activating VITT antibodies.

322. Application of a maximal-clique based community detection algorithm to gut microbiome data reveals driver microbes during influenza A virus infection.

323. Mathematical modeling of plus-strand RNA virus replication to identify broad-spectrum antiviral treatment strategies.

324. In-depth profiling of COVID-19 risk factors and preventive measures in healthcare workers.

325. Most anti-PF4 antibodies in vaccine-induced immune thrombotic thrombocytopenia are transient.

326. The proteogenomic subtypes of acute myeloid leukemia.

327. Convergent use of phosphatidic acid for hepatitis C virus and SARS-CoV-2 replication organelle formation.

328. Applications of artificial intelligence/machine learning approaches in cardiovascular medicine: a systematic review with recommendations.

329. Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19.

330. Modeling transcriptomic age using knowledge-primed artificial neural networks.

331. Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research.

332. Ionizing Radiation Alters the Transition/Transversion Ratio in the Exome of Human Gingiva Fibroblasts.

333. Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML.

334. Metabolic Cross-talk Between Human Bronchial Epithelial Cells and Internalized Staphylococcus aureus as a Driver for Infection.

335. Comparative proteomics reveals a diagnostic signature for pulmonary head-and-neck cancer metastasis.

336. Isolate-dependent use of claudins for cell entry by hepatitis C virus.

337. Aging is associated with highly defined epigenetic changes in the human epidermis.

338. Novel CIC point mutations and an exon-spanning, homozygous deletion identified in oligodendroglial tumors by a comprehensive genomic approach including transcriptome sequencing.

339. Reconstruction of cellular signal transduction networks using perturbation assays and linear programming.

340. High-throughput RNA interference screens integrative analysis: Towards a comprehensive understanding of the virus-host interplay.

341. Mining quasi-bicliques from HIV-1-human protein interaction network: a multiobjective biclustering approach.

342. A novel, diffusely infiltrative xenograft model of human anaplastic oligodendroglioma with mutations in FUBP1, CIC, and IDH1.

343. hepatitis c Virus p7 is critical for capsid assembly and envelopment.

344. Replication vesicles are load- and choke-points in the hepatitis C virus lifecycle.

345. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.

346. Rif2 promotes a telomere fold-back structure through Rpd3L recruitment in budding yeast.

347. Dynamic oscillation of translation and stress granule formation mark the cellular response to virus infection.

348. miR-17-5p regulates endocytic trafficking through targeting TBC1D2/Armus.

349. Hub-centered gene network reconstruction using automatic relevance determination.

350. MAP-kinase regulated cytosolic phospholipase A2 activity is essential for production of infectious hepatitis C virus particles.

Catalog

Books, media, physical & digital resources